Internal Medicine · Honolulu, HI
NPI
1376592378
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2525 S King St, Suite 306
Honolulu, HI, 96826
Phone (808) 949-4747
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,084 services
Medicare patients, 2024
274
Average age 79
Drug cost, 2024
$739K
5,207 prescriptions
Company payments, 2025
$502
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven W Dang was code 99214 (office e&m - established), 731 times for 272 patients. In total Steven W Dang billed 1,084 services in 10 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 731 | 272 | $80.50 | $59K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 223 | 223 | $134.39 | $30K |
| 90658 Vaccine Product | Office | 32 | 32 | $21.42 | $685 |
| G0008 Administration of influenza virus vaccine | Office | 32 | 32 | $33.52 | $1,073 |
| 93000 Electrocardiogram | Office | 27 | 25 | $10.64 | $287 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 18 | 16 | $233.46 | $4,202 |
By year: 2022 $110K for 1,359 services; 2023 $108K for 1,325 services; 2024 $98K for 1,084 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven W Dang prescribed most often to Medicare patients was Atorvastatin Calcium, with 488 prescriptions and refills. In total Steven W Dang wrote 5,207 Medicare prescriptions that cost $739K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 488 | 1,465 | 144 | $18K |
| Simvastatin Generic | 356 | 1,069 | 95 | $14K |
| Amlodipine Besylate Generic | 164 | 490 | 49 | $2,362 |
| Metformin Hcl Generic | 157 | 472 | 46 | $1,813 |
| Metoprolol Succinate Generic | 146 | 427 | 39 | $3,242 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 146 | 438 | 43 | $16K |
| Levothyroxine Sodium Generic | 135 | 397 | 37 | $622 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 126 | 377 | 34 | $6,316 |
| Hydrochlorothiazide Generic | 118 | 349 | 37 | $556 |
| Lisinopril Generic | 104 | 306 | 31 | $1,996 |
| Alendronate Sodium Generic | 100 | 280 | 29 | $1,849 |
| Glimepiride Generic | 100 | 299 | 30 | $4,866 |
| Prednisone Generic | 94 | 101 | 65 | $235 |
| Losartan Potassium Generic | 79 | 238 | 24 | $1,056 |
| Fluticasone Propionate Generic | 75 | 137 | 40 | $905 |
Brand drugs: 537 claims; generic drugs: 4,628 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven W Dang $502 ($502 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $381.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.